Cargando…
Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes
INTRODUCTION: Restless legs syndrome (RLS) affects 5–15% of adults, but is often unrecognized and consequently misdiagnosed. The International Restless Legs Scale (IRLS) has been developed and validated to assess the severity of RLS. Currently, the most common treatment for RLS is levodopa, but this...
Autor principal: | Winlow, William |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321653/ https://www.ncbi.nlm.nih.gov/pubmed/22496675 |
Ejemplares similares
-
Restless legs syndrome: differential diagnosis and management with pramipexole
por: Brindani, Francesca, et al.
Publicado: (2009) -
Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006) -
Does Pramipexole Treatment Improve Headache in Patients with Concomitant Migraine and Restless Legs Syndrome?
por: Suzuki, Keisuke, et al.
Publicado: (2013) -
Efficacy and tolerability of pramipexole for the treatment of primary restless leg syndrome: a meta-analysis of randomized placebo-controlled trials
por: Zhang, Wei, et al.
Publicado: (2013) -
Restless legs syndrome augmentation among Japanese patients receiving pramipexole therapy: Rate and risk factors in a retrospective study
por: Takahashi, Masayoshi, et al.
Publicado: (2017)